Collegium to Participate in Jefferies Global Healthcare Conference

STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference being held in New York, NY from June 5-6, 2024.

Details of the event are as follows:
Fireside Chat Date and Time: Wednesday, June 5, 2024, at 9:30 a.m. ET

The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contact:
Christopher James, M.D.
Vice President, Investor Relations
[email protected]

Media Contact:
Marissa Samuels
Vice President, Corporate Communications
[email protected]

You May Also Be Interested In

• The Cybersecurity Talent Gap Is an Economic Problem. Tolulope Michael Is Betting Non-Technical Workers Are the Answer
• Professional Powder Coating Limited: The Hidden Protection Behind North America’s Critical Infrastructure
• Solana Price Prediction Targets a $134 Recovery as AlphaPepe Passes $2.94M With Ex-Shibarium Talent Behind Its AI Exchange